≥ 10% от пациентите ≥ 1 до < 10% от пациентите повишено или намалено тегло (степен 3/ 4:
Very common adverse Common adverse reactions reactions ≥ 10% of patients ≥ 1 to < 10% of patients Weight increased or decreased (G3/ 4: